Search

Thomas Geelhaar, Head of Chemicals R&D at Merck in Darmstadt, Germany, describes how the company scouts for technologies and interacts with universities.

Radiologists are in short supply in parts of Europe. Telemedicine Clinic solves the problem by remote control, with a network of doctors who diagnose patients on the basis of medical images that arrive by email.

Corporate incubators bridge the seed funding gap, but apart from pocket money what can start-ups learn from their foster parents?

A Swedish report into levels of research funding for universities since the mid 1990s shows resources increased up to 2002 and then stagnated.

Scotland launched the latest version of its strategy to become one of world’s top locations for life sciences by 2020, as the hopes vested in two of its leading research companies Stem Cell Sciences and Ardana Biosciences, turned to dust.

Thin drug pipelines prompted the biopharmaceuticals licensing splurge of 2006/7. Now pharma and large biotechs are looking to tap into university research too.

Nuclear power is back in favour – but does Europe have the skills and resources to bring the industry into the 21st century?

The move from the warm embrace of global healthcare giant GE to a tiny biotech start-up was an exhilarating experience for Bill Clarke.

The European Commission wants member states to adopt a code of conduct for nanotechnology research at universities, research institutes and companies.